Real-World Analysis
XARELTO® Significantly Reduced Ischemic Stroke in Real-World Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulants
Janssen Pharmaceutical Companies
PR-M03-19-NI-044Mar 15, 2019
Real-World Study
New Real-World Study Finds Long-Term XARELTO® (rivaroxaban) Use Resulted in Fewer Strokes and Systemic Emboli
Janssen Pharmaceutical Companies
PR-M05-18-NI-101May 28, 2018